The global Anxiety Disorders in Diazepam Market, valued at USD 1.01 billion in 2019, is expected to reach USD 1.31 billion by 2027, growing at a CAGR of 3.4%. Diazepam is a benzodiazepine drug primarily used for treating central nervous system disorders such as anxiety, insomnia, muscle relaxation, seizures, and alcohol withdrawal.
While the market for Diazepam is expected to grow due...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek